Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rubeshan Perumal

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Viruses|June 27, 2025
Navigating Virology's Frontiers in Africa: Global Virus Network 2024 Durban MeetingMaggie L Bartlett, Rubeshan Perumal, Sten H Vermund, et al.
Expert Review of Clinical Pharmacology|August 23, 2023
Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infectionEmmanuella Chinonso Osuala, Anushka Naidoo, Kelly E Dooley, et al.
Pathogens (Basel, Switzerland)|January 22, 2024
Rapid Diagnosis of Drug-Resistant Tuberculosis-Opportunities and ChallengesKogieleum Naidoo, Rubeshan Perumal, Senamile L Ngema, et al.
Clinical Microbiology Reviews|October 6, 2022
The Changing Paradigm of Drug-Resistant Tuberculosis Treatment: Successes, Pitfalls, and Future PerspectivesNavisha Dookie, Senamile L Ngema, Rubeshan Perumal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2019
A Moxifloxacin-based Regimen for the Treatment of Recurrent, Drug-sensitive Pulmonary Tuberculosis: An Open-label, Randomized, Controlled TrialRubeshan Perumal, Nesri Padayatchi, Nonhlanhla Yende-Zuma, et al.
Infection and Drug Resistance|May 16, 2023
<i>Mycobacterium tuberculosis</i> Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing TreatmentRubeshan Perumal, Azraa Khan, Kogieleum Naidoo, et al.
Health and Human Rights|June 24, 2022
Mandatory COVID-19 Vaccination: Lessons from Tuberculosis and HIVLynette Mtimkulu-Eyde, Justin Denholm, Apurva Narain, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2018
Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral TherapyRubeshan Perumal, Neveen Abdelghani, Naressa Naidu, et al.
Iscience|June 2, 2023
Biological mechanisms underpinning the development of long COVIDRubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
AAS Open Research|May 9, 2020
Multiple microbiologic tests for tuberculosis improve diagnostic yield of bronchoscopy in medically complex patientsDilshaad Fakey Khan, Moosa Suleman, Prinita Baijnath, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Viruses|June 27, 2025
Navigating Virology's Frontiers in Africa: Global Virus Network 2024 Durban MeetingMaggie L Bartlett, Rubeshan Perumal, Sten H Vermund, et al.
Expert Review of Clinical Pharmacology|August 23, 2023
Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infectionEmmanuella Chinonso Osuala, Anushka Naidoo, Kelly E Dooley, et al.
Pathogens (Basel, Switzerland)|January 22, 2024
Rapid Diagnosis of Drug-Resistant Tuberculosis-Opportunities and ChallengesKogieleum Naidoo, Rubeshan Perumal, Senamile L Ngema, et al.
Clinical Microbiology Reviews|October 6, 2022
The Changing Paradigm of Drug-Resistant Tuberculosis Treatment: Successes, Pitfalls, and Future PerspectivesNavisha Dookie, Senamile L Ngema, Rubeshan Perumal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2019
A Moxifloxacin-based Regimen for the Treatment of Recurrent, Drug-sensitive Pulmonary Tuberculosis: An Open-label, Randomized, Controlled TrialRubeshan Perumal, Nesri Padayatchi, Nonhlanhla Yende-Zuma, et al.
Infection and Drug Resistance|May 16, 2023
<i>Mycobacterium tuberculosis</i> Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing TreatmentRubeshan Perumal, Azraa Khan, Kogieleum Naidoo, et al.
Health and Human Rights|June 24, 2022
Mandatory COVID-19 Vaccination: Lessons from Tuberculosis and HIVLynette Mtimkulu-Eyde, Justin Denholm, Apurva Narain, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2018
Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral TherapyRubeshan Perumal, Neveen Abdelghani, Naressa Naidu, et al.
Iscience|June 2, 2023
Biological mechanisms underpinning the development of long COVIDRubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
AAS Open Research|May 9, 2020
Multiple microbiologic tests for tuberculosis improve diagnostic yield of bronchoscopy in medically complex patientsDilshaad Fakey Khan, Moosa Suleman, Prinita Baijnath, et al.
Pageof 6